VRPX
VIRPAX PHARMS INCstockOTC
virpax pharmaceuticals specializes in developing new drug delivery systems across various indications to increase compliance and maximize the ability to achieve full therapeutic efficacy. we develop branded pharmaceutical products for pain management by using cutting-edge technology to enhance patients' quality of life, all while creating value for our investors and partners. we are focused on becoming a global leader in non-opioid pain management by developing and delivering innovative pharmaceutical products to our customers. virpax is committed to collaborating with its network of u.s. and global partners to advance the development of proprietary drug platforms that will produce the next generation of branded pharmaceutical products.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1M | 0.01 | 2026-09-17 | -99.99% | -126.599 |
| 3M | 0.01 | 2026-07-09 | -99.99% | 1150.377 |
| 6M | 0.01 | 2026-04-08 | -99.99% | 478.152 |
| 1Y | 0.02 | 2025-10-08 | -100.00% | -11816.535 |
| 2Y | 12.20 | 2024-10-08 | -100.00% | — |
| 5Y | 1,065.00 | 2021-10-08 | -100.00% | -632.974 |
VIRPAX PHARMS INC (OTC:VRPX) stock price today is $0.00, and today's volume is 1,092. VRPX is up 0.000% today. The 30 day average volume is 1,644. VRPX market cap is $1 with 1.24M shares outstanding.